The Psychedelic News Feed

October 6 - 12, 2025

This is an archived version of our Psychedelic News Feed. Explore the live Feed and receive a weekly digest to your inbox by joining our free newsletter:

Learn more about and subscribe to our Pα+ program to receive lots, lots more.

A Note from the Editor

It was a very busy week here at Psychedelic Alpha. On Thursday, we launched The Psychedelic Practitioner, a new publication designed specifically for therapists, clinicians, facilitators, and other professionals working with—or preparing to work with—psychedelic therapies and related treatments. Issue 1 is now available to read, and we welcome your feedback via the survey.

Friday was World Mental Health Day, which saw media outlets across the world spotlighting psychedelics’ potential in this realm. I was very pleased that my interview with journalist Dominique Nora was featured in French magazine Le Nouvel Obs’ Friday special. There, I discussed how the psychedelics field has changed in the past half-decade, what the pipeline looks like today, the challenges that psychedelic studies and rollout are facing, or might face, and a brief outlook on the future of the field.

Elsewhere, CBS News featured our U.S. psychedelic laws tracker in a segment on “The rise of psychedelic-assisted therapy for mental health treatment”, which saw Dr. Rachel Yehuda interviewed by the morning show’s anchors. 

But the week ended on a sombre note, as we learned that Dr. Nolan Williams had died by suicide. Williams was a Stanford researcher whose work reshaped modern brain stimulation treatments for depression and suicidality. More recently, he became a prominent voice in the psychedelics research field, especially on the ibogaine front. This shocking news underscores the enormity of the struggle he fought to tackle through his own work. But those close to Williams have already expressed that his vision and compassion will continue to shape the field he redefined. Yesterday, psychiatrist Owen Scott Muir, who described Williams as both a friend and a hero, published a eulogy.

Below, you will find your Psychedelic News Feed, a one-stop digest for the latest coverage of psychedelics business, policy, research and beyond.

Josh Hardman
Founder & Editor

The Psychedelic Practitioner: Issue I (Oct 9) ↗ Psychedelic Alpha
An Interview with Psychedelic Alpha Founder Josh Hardman (Oct 10) ↗ Le Nouvel Obs
The rise of psychedelic-assisted therapy for mental health treatment (Oct 10) ↗ CBS News
Q3 2025: Psychedelic Investor Survey Topline Results (Oct 7) ↗ Psychedelic Alpha
Q2 2025: Oregon Psilocybin Services Tracker (Oct 10) ↗ Psychedelic Alpha
Q2 2025: Oregon Psilocybin Services Update (Oct 10) ↗ Psychedelic Alpha (A summary of the changes for our Pα+ subscribers.)
Cops on Ketamine? Largely Unregulated Mental Health Treatment Faces Hurdles (Oct 10) ↗ KFF Health News
David Nutt to tell Argentine conference: international psychedelics ban should be revoked ASAP (Oct 7) ↗ Buenos Aires Herald
International Society for Research on Psychedelics (ISRP) 2026 Abstract Submissions Open ↗ More Info & Submit

Healthcare execs on the state of psychedelic medicine (Oct 7) ↗ Healthcare Brew

From trips to treatments: how psychedelics could revolutionise anti-inflammatory medicine (Oct 6) ↗ The Conversation

Is Ibogaine a New Lifeline? (Oct 7) ↗ Westword

Can MDMA help psychiatric disorders? Sam Altman and founders of Coinbase and Figma are betting on it (Oct 9) ↗ SF Business Times

This Tour pro took a psychedelic drug. It led to a new business (Oct 9) ↗ Golf.com

This is an archived version of our Psychedelic News Feed. Explore the live Feed and receive a weekly digest to your inbox by joining our free newsletter:

Learn more about and subscribe to our Pα+ program to receive lots, lots more.